Ernexa Therapeutics Inc. Deferred Revenue
Ernexa Therapeutics Inc. (ERNA) had Deferred Revenue of $189.00 thousand as of 2024-06-30, per its 10-Q filed 2024-08-13.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Deferred Revenue, Current
us-gaap:DeferredRevenueCurrent · last filed 2025-03-12
- 2024-06-30: Deferred Revenue, Current $189.00K.
- 2024-03-31: Deferred Revenue, Current $189.00K.
- 2023-12-31: Deferred Revenue, Current $190.00K.
- 2023-09-30: Deferred Revenue, Current $349.00K.
| Period end | Deferred Revenue, Current | Deferred Revenue, Current as first filed |
|---|---|---|
| 2024-06-30 | $189.00K 10-Q · filed 2024-08-13 | |
| 2024-03-31 | $189.00K 10-Q · filed 2024-05-14 | |
| 2023-12-31 | $190.00K 10-K · filed 2025-03-12 | |
| 2023-09-30 | $349.00K 10-Q · filed 2023-11-13 | |
| 2022-12-31 | $0.00 10-K · filed 2024-03-14 | |
| 2020-12-31 | $76.00K 10-K · filed 2021-03-11 | |
| 2020-09-30 | $120.00K 10-Q · filed 2020-11-13 | |
| 2020-06-30 | $377.00K 10-Q · filed 2020-08-07 | |
| 2020-03-31 | $383.00K 10-Q · filed 2020-05-20 | |
| 2019-12-31 | $460.00K 10-K · filed 2021-03-11 | |
| 2019-09-30 | $743.00K 10-Q · filed 2019-11-01 | |
| 2019-06-30 | $518.00K 10-Q · filed 2019-08-12 | |
| 2019-03-31 | $1.19M 10-Q · filed 2019-05-14 | |
| 2018-12-31 | $1.27M 10-K · filed 2020-03-19 | $1.37M 10-K · filed 2019-03-22 |
| 2018-09-30 | $2.49M 10-Q · filed 2018-11-09 | |
| 2018-06-30 | $2.85M 10-Q · filed 2018-08-06 | |
| 2018-03-31 | $3.40M 10-Q · filed 2018-05-11 | |
| 2017-12-31 | $3.56M 10-K · filed 2019-03-22 | |
| 2017-09-30 | $3.71M 10-Q · filed 2017-11-08 | |
| 2017-06-30 | $3.84M 10-Q · filed 2017-08-04 | |
| 2017-03-31 | $1.04M 10-Q · filed 2017-05-04 | |
| 2016-12-31 | $1.06M 10-K · filed 2018-03-09 | |
| 2016-09-30 | $1.38M 10-Q · filed 2016-11-09 | |
| 2016-06-30 | $1.35M 10-Q · filed 2016-08-04 | |
| 2016-03-31 | $1.27M 10-Q · filed 2016-05-09 | |
| 2015-12-31 | $1.21M 10-K · filed 2017-03-09 | |
| 2015-09-30 | $1.98M 10-Q · filed 2015-11-09 | |
| 2015-06-30 | $1.81M 10-Q · filed 2015-08-10 | |
| 2015-03-31 | $2.32M 10-Q · filed 2015-05-08 | |
| 2014-12-31 | $1.84M 10-K · filed 2016-03-15 | |
| 2014-09-30 | $1.62M 10-Q · filed 2014-11-07 | |
| 2014-06-30 | $1.37M 10-Q · filed 2014-08-14 | |
| 2014-03-31 | $1.06M 10-Q · filed 2014-05-15 | |
| 2013-12-31 | $593.00K 10-K · filed 2015-03-27 | |
| 2013-09-30 | $515.00K 10-Q · filed 2013-11-14 | |
| 2013-06-30 | $546.00K 10-Q · filed 2013-08-14 | |
| 2013-03-31 | $542.00K 10-Q · filed 2013-05-13 | |
| 2012-12-31 | $919.00K 10-K · filed 2014-03-31 | |
| 2012-09-30 | $611.00K 10-Q · filed 2012-11-09 | |
| 2012-06-30 | $564.00K 10-Q · filed 2012-08-14 | |
| 2012-03-31 | $499.00K 10-Q · filed 2012-05-11 | |
| 2011-12-31 | $463.00K 10-K · filed 2013-03-29 | |
| 2011-09-30 | $537.00K 10-Q · filed 2011-11-14 | |
| 2011-06-30 | $567.00K 10-Q · filed 2011-08-12 | |
| 2010-12-31 | $520.00K 10-K · filed 2012-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B |